Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...
JD Supra

IPR or EPR? Five Scenarios and a Decision Tree for Post-Grant Patent Challengers in the Life Sciences

The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...
Healthcare Asia Magazine on MSN

DNA diagnostics market to reach $24.7B by 2034 on precision medicine, genomic advancements

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...
Le Lézard

Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarketstm

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
StockStory.org on MSN

1 high-flying stock with solid fundamentals and 2 we find risky

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...